Gram-Negative Bacterial Infections Clinical Trial
Official title:
A Multicenter, Single-arm, Open-label Study to Assess the Pharmacokinetics, Safety, and Tolerability of Cefiderocol in Hospitalized Pediatric Patients From Birth to < 3 Months of Age With Suspected or Confirmed Aerobic Gram-negative Bacterial Infections
The primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 months of age with suspected or confirmed aerobic Gram-negative bacterial infections.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00723502 -
Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients
|
Phase 2 | |
| Completed |
NCT00177814 -
Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit
|
||
| Suspended |
NCT00563134 -
A Randomised Trial on the Saftely and Efficacy of GR270774 in the Treatment of Gram-negative Sepsis in Adult
|
N/A | |
| Active, not recruiting |
NCT05171257 -
Quantifying Gram-negative Resistance to Empiric Therapy in the Intensive Care Unit
|
||
| Completed |
NCT03160040 -
A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Minocin® (Minocycline) for Infections Caused by Gram-negative Bacteria in a Real World Setting
|
||
| Completed |
NCT02962934 -
An Observational Pharmacokinetic Sudy of Ceftolozane-Tazobactam in Intensive Care Unit in Patients With and Without CRRT
|
||
| Not yet recruiting |
NCT06135350 -
Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV
|
Phase 2 | |
| Enrolling by invitation |
NCT04055922 -
Comparison of Solid Organ Transplant
|
||
| Completed |
NCT00490477 -
The Effects of Polymyxin-B Protects on Sepsis Induced Kidney Dysfunction: a Randomized Clinical Trial
|
Phase 3 | |
| Recruiting |
NCT04861922 -
Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection
|
Phase 3 | |
| Completed |
NCT01732250 -
Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
|
Phase 4 | |
| Completed |
NCT00406198 -
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
|
Phase 4 | |
| Withdrawn |
NCT04785924 -
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
|
Phase 4 | |
| Completed |
NCT02285075 -
Temocillin Pharmacokinetic in Hemodialysis
|
Phase 4 | |
| Completed |
NCT03182504 -
A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT04917380 -
The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens.
|
||
| Terminated |
NCT05210387 -
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
|
N/A | |
| Completed |
NCT03397914 -
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
|
Phase 4 | |
| Completed |
NCT02088840 -
Survey of Severe Infections by Gram Negative Bacteria in Patients Submitted to Stem Cell Transplant
|
||
| Recruiting |
NCT01600768 -
Evaluation of Extended Intravenous of Beta-lactams in the Treatment of Serious Gram-negative Infections in Critically Ill Patients
|
N/A |